Bioxcel Therapeutics Inc (NQ: BTAI )

53.61 USD -1.54 (-2.79%)

Official Closing Price Updated: 4:34 PM EST, Feb 26, 2021 Add to My Watchlist

Price and Volume

Volume	393,400
Open	54.45
Bid (Size)	50.07 (1)
Ask (Size)	58.00 (7)
Prev. Close	55.15
Today's Range	51.53 - 56.86
52wk Range	13.77 - 71.50
Shares Outstanding	15,645,545
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

BioXcel Therapeutics Announces Initiation of Phase 2 PLACIDITY Trial of BXCL501 for the Treatment of Delirium Related Agitation

February 25, 2021

Topline results are expected in Q1 2022

BioXcel Therapeutics Appoints Javier Rodriguez as Chief Legal Officer and Corporate Secretary

February 23, 2021

Performance

YTD	+2.60%	+2.60%
1 Month	+15.91%	+15.91%
3 Month	+21.84%	+21.84%
6 Month	+31.56%	+31.56%
1 Year	+42.96%	+42.96%

More News

BioXcel Therapeutics to Host Virtual Key Opinion Leader Event to Highlight BXCL501 as a Potential Treatment for Agitation and Opioid Withdrawal Symptoms

February 12, 2021

BioXcel Therapeutics to Present an Update from its Ongoing Trial of BXCL701 in Aggressive Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium

February 04, 2021

BioXcel Therapeutics Announces BXCL501 Met the Primary and All Secondary Endpoints in the TRANQUILITY Phase 1b/2 Study for the Acute Treatment of Agitation in Dementia, including Alzheimer’s Disease

January 05, 2021

BioXcel Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

December 17, 2020

BioXcel Therapeutics Announces Grant by U.S. Department of Defense to Evaluate BXCL501 in Patients Suffering from PTSD

December 07, 2020

BioXcel Therapeutics Starts Testing BXCL501 In Mid-Stage Delirium-Related Agitation Study

February 25, 2021

BioXcel Therapeutics Breaks Below 200-Day Moving Average - Notable for BTAI

January 28, 2021

Implied LABU Analyst Target Price: $160

January 14, 2021

10 Biggest Price Target Changes For Wednesday

January 06, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.